Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LINO-1713 in Healthy Korean Female Subjects
Clinical trial NCT05677035 · COMPLETED
Trial details
- NCT number
- NCT05677035
- Sponsor
- Hyundai Pharm
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-11
- Primary completion
- 2022-06-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.